Perceptive Advisors


Perceptive Advisors, founded in 1999, is a venture capital firm focused on supporting progress in the life sciences industry. The firm manages approximately $8 billion across various strategies, investing in transformative technologies within healthcare. Perceptive Advisors is dedicated to identifying opportunities and directing financial resources toward the most promising innovations in modern healthcare, with a strong emphasis on scientific, technical, and investment expertise.

Perceptive Advisors

Perceptive Advisors


What We Do

Perceptive Advisors provides venture capital through the Perceptive Xontogeny Venture Fund, focusing on early-stage life sciences companies, primarily seed and Series A investments. The firm partners with founders and entrepreneurs, offering operational and strategic support as Board members to drive successful outcomes.

The firm offers customized debt financing solutions to innovative healthcare companies, providing minimally-dilutive capital across all stages and subsectors. This includes funding for R&D, acquisitions, and commercial scale-up.

Perceptive Discovery Fund provides capital solutions to high conviction private and public life sciences company opportunities, focusing on later-stage development and commercial-stage companies. The fund offers structured solutions in the form of preferred equity and/or convertible debt.


Geographic Focus

Investment Range


Portfolio

Creating and developing optimized AAV vectors for gene therapy.

#Biopharmaceuticals

Developing novel cancer immunotherapies targeting clonal neoantigens.

#Biopharmaceuticals

Pioneering Adaptive Vapor Ablation technology for patient therapies.

#Medical Devices

Focused on women's healthcare, addressing unmet health needs.

#Healthcare

Specialty pharmaceutical company leveraging PharmFilm technology.

#Pharmaceuticals


Key People

Chief Executive Officer & Portfolio Manager

Chief Investment Officer

Managing Director